Literature DB >> 21622935

Replacement of the myotonic dystrophy type 1 CTG repeat with 'non-CTG repeat' insertions in specific tissues.

Michelle M Axford1, Arturo López-Castel, Masayuki Nakamori, Charles A Thornton, Christopher E Pearson.   

Abstract

BACKGROUND: Recently, curious mutations have been reported to occur within the (CTG)n repeat tract of the myotonic dystrophy type 1 (DM1) locus. For example, the repeat, long presumed to be a pure repeat sequence, has now been revealed to often contain interruption motifs in a proportion of cases with expansions. Similarly, a few de novo somatic CTG expansions have been reported to arise from non-expanded DM1 alleles with 5-37 units, thought to be genetically stable. AIMS AND METHODS: This study has characterised a novel mutation configuration at the DM1 CTG repeat that arose as somatic mosaicism in a juvenile onset DM1 patient with a non-expanded allele of (CTG)12 and tissue specific expansions ranging from (CTG)1100 to 6000.
RESULTS: The mutation configuration replaced the CTG tract with a non-CTG repeat insertion of 43 or 60 nucleotides, precisely placed in the position of the CTG tract with proper flanking sequences. The inserts appeared to arise from a longer human sequence on chromosome 4q12, and may have arisen through DNA structure mediated somatic inter-gene recombination or replication/repair template switching errors. De novo insertions were detected in cerebral cortex and skeletal muscle, but not in heart or liver. Repeat tracts with -1 or -2 CTG units were also detected in cerebellum, which may have arisen by contractions of the short (CTG)12 allele.
CONCLUSION: This non-CTG configuration expands current understanding of the sequence variations that can arise at this hypermutable site.

Entities:  

Mesh:

Year:  2011        PMID: 21622935      PMCID: PMC3379714          DOI: 10.1136/jmg.2010.085944

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  35 in total

1.  The draft sequences. Filling in the gaps.

Authors:  P Bork; R Copley
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

2.  Microsatellite instability (MSI) increases with age in normal somatic cells.

Authors:  Mary I Coolbaugh-Murphy; Jingping Xu; Louis S Ramagli; Barry W Brown; Michael J Siciliano
Journal:  Mech Ageing Dev       Date:  2005-10       Impact factor: 5.432

3.  Mutagenesis by transient misalignment.

Authors:  T A Kunkel; A Soni
Journal:  J Biol Chem       Date:  1988-10-15       Impact factor: 5.157

4.  Increased mutagenesis and unique mutation signature associated with mitotic gene conversion.

Authors:  Wade M Hicks; Minlee Kim; James E Haber
Journal:  Science       Date:  2010-07-02       Impact factor: 47.728

5.  Slipped-strand DNAs formed by long (CAG)*(CTG) repeats: slipped-out repeats and slip-out junctions.

Authors:  Christopher E Pearson; Mandy Tam; Yuh-Hwa Wang; S Erin Montgomery; Arvin C Dar; John D Cleary; Kerrie Nichol
Journal:  Nucleic Acids Res       Date:  2002-10-15       Impact factor: 16.971

6.  Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene.

Authors:  C A Thornton; J P Wymer; Z Simmons; C McClain; R T Moxley
Journal:  Nat Genet       Date:  1997-08       Impact factor: 38.330

7.  Alternative structures in duplex DNA formed within the trinucleotide repeats of the myotonic dystrophy and fragile X loci.

Authors:  C E Pearson; R R Sinden
Journal:  Biochemistry       Date:  1996-04-16       Impact factor: 3.162

8.  Deletion mapping of chromosome 4q22-35 and identification of four frequently deleted regions in head and neck cancers.

Authors:  E Cetin; B Cengiz; E Gunduz; M Gunduz; H Nagatsuka; L Bekir-Beder; K Fukushima; D Pehlivan; M Ozaslan N; K Nishizaki; K Shimizu; N Nagai
Journal:  Neoplasma       Date:  2008       Impact factor: 2.575

9.  Friedreich's ataxia (GAA)n•(TTC)n repeats strongly stimulate mitotic crossovers in Saccharomyces cerevisae.

Authors:  Wei Tang; Margaret Dominska; Patricia W Greenwell; Zachary Harvanek; Kirill S Lobachev; Hyun-Min Kim; Vidhya Narayanan; Sergei M Mirkin; Thomas D Petes
Journal:  PLoS Genet       Date:  2011-01-13       Impact factor: 5.917

10.  Closing gaps in the human genome using sequencing by synthesis.

Authors:  Manuel Garber; Michael C Zody; Harindra M Arachchi; Aaron Berlin; Sante Gnerre; Lisa M Green; Niall Lennon; Chad Nusbaum
Journal:  Genome Biol       Date:  2009-06-02       Impact factor: 13.583

View more
  5 in total

1.  Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes.

Authors:  Ellis Y Kim; David Y Barefield; Andy H Vo; Anthony M Gacita; Emma J Schuster; Eugene J Wyatt; Janel L Davis; Biqin Dong; Cheng Sun; Patrick Page; Lisa Dellefave-Castillo; Alexis Demonbreun; Hao F Zhang; Elizabeth M McNally
Journal:  JCI Insight       Date:  2019-03-21

2.  Analysis of microsatellite variation in Drosophila melanogaster with population-scale genome sequencing.

Authors:  John W Fondon; Andy Martin; Stephen Richards; Richard A Gibbs; David Mittelman
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

3.  FRA2A is a CGG repeat expansion associated with silencing of AFF3.

Authors:  Sofie Metsu; Liesbeth Rooms; Jacqueline Rainger; Martin S Taylor; Hemant Bengani; David I Wilson; Chandra Sekhar Reddy Chilamakuri; Harris Morrison; Geert Vandeweyer; Edwin Reyniers; Evelyn Douglas; Geoffrey Thompson; Eric Haan; Jozef Gecz; David R Fitzpatrick; R Frank Kooy
Journal:  PLoS Genet       Date:  2014-04-24       Impact factor: 5.917

Review 4.  Molecular genetics and genetic testing in myotonic dystrophy type 1.

Authors:  Dušanka Savić Pavićević; Jelena Miladinović; Miloš Brkušanin; Saša Šviković; Svetlana Djurica; Goran Brajušković; Stanka Romac
Journal:  Biomed Res Int       Date:  2013-03-18       Impact factor: 3.411

Review 5.  Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy.

Authors:  Laurène M André; C Rosanne M Ausems; Derick G Wansink; Bé Wieringa
Journal:  Front Neurol       Date:  2018-05-28       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.